Menu
Log in
Forgot password


Log in


PGRN Research in Progress Seminar: "Investigating the impact of the novel CYP2C:TG haplotype on escitalopram exposure: A CAN-BIND-1 study report"

  • Wed, August 12, 2026
  • 11:00 AM - 12:00 PM

PGRN Research in Progress Series
Hosted by the PGRN Education Committee
8:00 PDT / 11:00 EDT / 17:00 CEST

Speakers

"Investigating the impact of the novel CYP2C:TG haplotype on escitalopram exposure: A CAN-BIND-1 study report"




Dr. Leen Magarbeh, PhD
Assistant Professor of Pharmacology
Yarmouk University, Jordan







Members Only Zoom Links

PGRN awards, seminars and meetings are usually for Members Only. Join now so you can take advantage of PGRN's seminars, research in progress sessions, toolkits and awards.


Copyright © 2020 the Pharmacogenomics Global Research Network.

All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Powered by Wild Apricot Membership Software